miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2.

Ma, Hai-Feng; Lv, Guo-Xiao; Zhang, Da-Hai

Ma, Hai-Feng; Lv, Guo-Xiao; Zhang, Da-Hai.

Afiliação

Ma HF; Department of Radiotherapy, Zhejiang Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, People's Republic of China.
Lv GX; Department of Radiotherapy, Zhejiang Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, People's Republic of China.
Zhang DH; Department of Radiotherapy, Zhejiang Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, People's Republic of China.

Onco Targets Ther ; 13: 4485-4493, 2020.

Article em En | MEDLINE | ID: mdl-32547079

Palavras-chave

FAK/PI3K/Akt/mTOR; HNSCC; STC2; miR-381

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2020 Tipo de documento: Article